Astellas Pharma Inc.  is a Japanese Pharmaceutical Company formed on 1 April 2005 by merging  Yamanouchi Pharmaceutical and Fujisawa Pharmaceutical.

Our headquarters is situated in Tokyo with two research centres in Tsukuba and Osaka.  Around 17000 employees are working with us globally.

Our franchise areas are urology, immunology (transplantation), dermatology, cardiology, and infectious disease. Priority areas of R & D are infectious diseases, diabetes, gastrointestinal diseases, oncology and diseases of central nervous system.